The role of miRNAs in progesterone action

Molecular and Cellular Endocrinology

Volumn 357, Issue 1-2, 2012, Pages 50-59

  Cochrane, Dawn R ^a   Spoelstra, Nicole S ^a   Richer, Jennifer K ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Breast; MiRNA; Progesterone receptor; Progestin; Uterus

Indexed keywords

FOLLITROPIN; GESTAGEN; MICRORNA; MICRORNA 125B; MICRORNA 181; MICRORNA 193 3P; MICRORNA 20; MICRORNA 200B; MICRORNA 200C; MICRORNA 203; MICRORNA 204; MICRORNA 21; MICRORNA 210; MICRORNA 26A; MICRORNA 29B; MICRORNA 29C; MICRORNA 30B; MICRORNA 30D; MICRORNA 31; MICRORNA 320; MICRORNA 345; MICRORNA 424; MICRORNA 429; MICRORNA 451; MICRORNA 453 3P; MICRORNA 582 5P; PROGESTERONE; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ANATOMICAL VARIATION; BREAST CANCER; CANCER CELL; DISEASE ASSOCIATION; DRUG EFFICACY; ENDOMETRIOSIS; ENZYME INHIBITION; ENZYME REGULATION; ESTRUS CYCLE; GRANULOSA CELL; HUMAN; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; UTERUS DISEASE; UTERUS MYOMA;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; RECEPTORS, PROGESTERONE; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84860321101     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.09.022     Document Type: Review

References (153)

1. Ace C.I., Okulicz W.C. Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase. Reprod. Biol. Endocrinol. 2004, 2:54.
2. Adams B.D., Furneaux H., White B.A. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol. Endocrinol. 2007, 21:1132-1147.
3. Aghajanova L., Giudice L.C. Molecular evidence for differences in endometrium in severe versus mild endometriosis. Reprod. Sci. 2011, 18:229-251.
4. Ahn H.W., Morin R.D., Zhao H., Harris R.A., Coarfa C., Chen Z.J., Milosavljevic A., Marra M.A., Rajkovic A. MicroRNA transcriptome in the newborn mouse ovaries determined by massive parallel sequencing. Mol. Hum. Reprod. 2010, 16:463-471.
5. Asselin-Labat M.L., Vaillant F., Sheridan J.M., Pal B., Wu D., Simpson E.R., Yasuda H., Smyth G.K., Martin T.J., Lindeman G.J., Visvader J.E. Control of mammary stem cell function by steroid hormone signalling. Nature 2010, 465:798-802.
6. Attia G.R., Zeitoun K., Edwards D., Johns A., Carr B.R., Bulun S.E. Progesterone receptor isoform A but not B is expressed in endometriosis. J. Clin. Endocrinol. Metab. 2000, 85:2897-2902.
7. Avril-Sassen S., Goldstein L.D., Stingl J., Blenkiron C., Le Quesne J., Spiteri I., Karagavriilidou K., Watson C.J., Tavare S., Miska E.A., Caldas C. Characterisation of microRNA expression in post-natal mouse mammary gland development. BMC Genomics. 2009, 10:548.
8. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell. 2009, 136:215-233.
9. Bernstein E., Kim S.Y., Carmell M.A., Murchison E.P., Alcorn H., Li M.Z., Mills A.A., Elledge S.J., Anderson K.V., Hannon G.J. Dicer is essential for mouse development. Nat. Genet. 2003, 35:215-217.
10. Borchert G.M., Lanier W., Davidson B.L. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 2006, 13:1097-1101.
11. Brabletz S., Brabletz T. The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer?. EMBO Rep. 2010, 11:670-677.
12. Bracken C.P., Gregory P.A., Kolesnikoff N., Bert A.G., Wang J., Shannon M.F., Goodall G.J. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008, 68:7846-7854.
13. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9:582-589.
14. Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., Schonbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y. The transcriptional landscape of the mammalian genome. Science 2005, 309:1559-1563.
15. Castellano L., Giamas G., Jacob J., Coombes R.C., Lucchesi W., Thiruchelvam P., Barton G., Jiao L.R., Wait R., Waxman J., Hannon G.J., Stebbing J. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc. Natl. Acad. Sci. USA 2009, 106:15732-15737.
16. Catherino W.H., Malik M., Driggers P., Chappel S., Segars J., Davis J. Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium. J. Steroid Biochem. Mol. Biol. 2010, 122:279-286.
17. Caudy A.A., Myers M., Hannon G.J., Hammond S.M. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev. 2002, 16:2491-2496.
18. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
19. Chin L.J., Ratner E., Leng S., Zhai R., Nallur S., Babar I., Muller R.U., Straka E., Su L., Burki E.A., Crowell R.E., Patel R., Kulkarni T., Homer R., Zelterman D., Kidd K.K., Zhu Y., Christiani D.C., Belinsky S.A., Slack F.J., Weidhaas J.B. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res. 2008, 68:8535-8540.
20. Choi Y., Qin Y., Berger M.F., Ballow D.J., Bulyk M.L., Rajkovic A. Microarray analyses of newborn mouse ovaries lacking Nobox. Biol. Reprod. 2007, 77:312-319.
21. Chu Y., Yue X., Younger S.T., Janowski B.A., Corey D.R. Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter. Nucleic Acids Res. 2010, 38:7736-7748.
22. Cochrane D., Cittelly D., Howe E., Spoelstra N., McKinsey E., LaPara K., Elias A., Yee D., Richer J. MicroRNAs link estrogen receptor alpha status and dicer levels in breast cancer. Hormones Cancer 2010, 1:306-309.
23. Cochrane D.R., Spoelstra N.S., Howe E.N., Nordeen S.K., Richer J.K. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol. Cancer Ther. 2009, 8:1055-1066.
24. Cohen A., Shmoish M., Levi L., Cheruti U., Levavi-Sivan B., Lubzens E. Alterations in micro-ribonucleic acid expression profiles reveal a novel pathway for estrogen regulation. Endocrinology 2008, 149:1687-1696.
25. Condon J.C., Jeyasuria P., Faust J.M., Wilson J.W., Mendelson C.R. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc. Natl. Acad. Sci. USA 2003, 100:9518-9523.
26. Crudden G., Loesel R., Craven R.J. Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors. Tumour Biol. 2005, 26:142-146.
27. Cui W., Li Q., Feng L., Ding W. miR-126-3p regulates progesterone receptors and involves development and lactation of mouse mammary gland. Mol. Cell. Biochem. 2011, 355:17-25.
28. Didiano D., Hobert O. Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat. Struct. Mol. Biol. 2006, 13:849-851.
29. Easow G., Teleman A.A., Cohen S.M. Isolation of microRNA targets by miRNP immunopurification. RNA 2007, 13:1198-1204.
30. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79:351-379.
31. Faggad A., Budczies J., Tchernitsa O., Darb-Esfahani S., Sehouli J., Muller B.M., Wirtz R., Chekerov R., Weichert W., Sinn B., Mucha C., Elwali N.E., Schafer R., Dietel M., Denkert C. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression. J. Pathol. 2010, 220:382-391.
32. Forstemann K., Tomari Y., Du T., Vagin V.V., Denli A.M., Bratu D.P., Klattenhoff C., Theurkauf W.E., Zamore P.D. Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein. PLoS Biol. 2005, 3:e236.
33. Fujimoto J., Hirose R., Ichigo S., Sakaguchi H., Li Y., Tamaya T. Expression of progesterone receptor form A and B mRNAs in uterine leiomyoma. Tumour Biol. 1998, 19:126-131.
34. Golan D., Levy C., Friedman B., Shomron N. Biased hosting of intronic microRNA genes. Bioinformatics 2010, 26:992-995.
35. Gonzalez G., Behringer R.R. Dicer is required for female reproductive tract development and fertility in the mouse. Mol. Reprod. Dev. 2009, 76:678-688.
36. Graham J.D., Mote P.A., Salagame U., van Dijk J.H., Balleine R.L., Huschtscha L.I., Reddel R.R., Clarke C.L. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology 2009, 150:3318-3326.
37. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10:593-601.
38. Gregory R.I., Chendrimada T.P., Shiekhattar R. MicroRNA biogenesis: isolation and characterization of the microprocessor complex. Methods Mol. Biol. 2006, 342:33-47.
39. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
40. Grelier G., Voirin N., Ay A.S., Cox D.G., Chabaud S., Treilleux I., Leon-Goddard S., Rimokh R., Mikaelian I., Venoux C., Puisieux A., Lasset C., Moyret-Lalle C. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br. J. Cancer 2009, 101:673-683.
41. Grimson A., Farh K.K., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27:91-105.
42. Gu J., Fu H., Zhang X., Li Y. Identifications of conserved 7-mers in 3'-UTRs and microRNAs in Drosophila. BMC Bioinf. 2007, 8:432.
43. Gu S., Jin L., Zhang F., Sarnow P., Kay M.A. Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs. Nat. Struct. Mol. Biol. 2009, 16:144-150.
44. Guay C., Roggli E., Nesca V., Jacovetti C., Regazzi R. Diabetes mellitus, a microRNA-related disease?. Transl Res. 2011, 157:253-264.
45. Guo S., Lu J., Schlanger R., Zhang H., Wang J.Y., Fox M.C., Purton L.E., Fleming H.H., Cobb B., Merkenschlager M., Golub T.R., Scadden D.T. MicroRNA miR-125a controls hematopoietic stem cell number. Proc. Natl. Acad. Sci. USA 2010, 107:14229-14234.
46. Han J., Lee Y., Yeom K.H., Kim Y.K., Jin H., Kim V.N. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 2004, 18:3016-3027.
47. Hardy D.B., Janowski B.A., Corey D.R., Mendelson C.R. Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression. Mol. Endocrinol. 2006, 20:2724-2733.
48. He Y., Vogelstein B., Velculescu V.E., Papadopoulos N., Kinzler K.W. The antisense transcriptomes of human cells. Science 2008, 322:1855-1857.
49. Henke J.I., Goergen D., Zheng J., Song Y., Schuttler C.G., Fehr C., Junemann C., Niepmann M. MicroRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J. 2008, 27:3300-3310.
50. Horwitz K.B., Sartorius C.A. Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis. J. Clin. Endocrinol. Metab. 2008, 93:3295-3298.
51. Hu H.Y., Yan Z., Xu Y., Hu H., Menzel C., Zhou Y.H., Chen W., Khaitovich P. Sequence features associated with microRNA strand selection in humans and flies. BMC Genom. 2009, 10:413.
52. Hu S.J., Ren G., Liu J.L., Zhao Z.A., Yu Y.S., Su R.W., Ma X.H., Ni H., Lei W., Yang Z.M. MicroRNA expression and regulation in mouse uterus during embryo implantation. J. Biol. Chem. 2008, 283:23473-23484.
53. Hurteau G.J., Carlson J.A., Spivack S.D., Brock G.J. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007, 67:7972-7976.
54. Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T., Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001, 293:834-838.
55. Hutvagner G., Zamore P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060.
56. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Menard S., Palazzo J.P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M., Croce C.M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-7070.
57. Jacobsen B.M., Richer J.K., Sartorius C.A., Horwitz K.B. Expression profiling of human breast cancers and gene regulation by progesterone receptors. J. Mammary Gland Biol. Neoplasia 2003, 8:257-268.
58. Janowski B.A., Corey D.R. Minireview: Switching on progesterone receptor expression with duplex RNA. Mol. Endocrinol. 2010, 24:2243-2252.
59. Janowski B.A., Younger S.T., Hardy D.B., Ram R., Huffman K.E., Corey D.R. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat. Chem. Biol. 2007, 3:166-173.
60. Joshi P.A., Jackson H.W., Beristain A.G., Di Grappa M.A., Mote P.A., Clarke C.L., Stingl J., Waterhouse P.D., Khokha R. Progesterone induces adult mammary stem cell expansion. Nature 2010, 465:803-807.
61. Kanellopoulou C., Muljo S.A., Kung A.L., Ganesan S., Drapkin R., Jenuwein T., Livingston D.M., Rajewsky K. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 2005, 19:489-501.
62. Kapranov P., Cheng J., Dike S., Nix D.A., Duttagupta R., Willingham A.T., Stadler P.F., Hertel J., Hackermuller J., Hofacker I.L., Bell I., Cheung E., Drenkow J., Dumais E., Patel S., Helt G., Ganesh M., Ghosh S., Piccolboni A., Sementchenko V., Tammana H., Gingeras T.R. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316:1484-1488.
63. Ketting R.F., Fischer S.E., Bernstein E., Sijen T., Hannon G.J., Plasterk R.H. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. Elegans. Genes Dev. 2001, 15:2654-2659.
64. Kim Y.K., Kim V.N. Processing of intronic microRNAs. EMBO J. 2007, 26:775-783.
65. Klinge C.M. Estrogen Regulation of MicroRNA Expression. Curr. Genomics 2009, 10:169-183.
66. Kok K.H., Ng M.H., Ching Y.P., Jin D.Y. Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J. Biol. Chem. 2007, 282:17649-17657.
67. Korpal M., Lee E.S., Hu G., Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008, 283:14910-14914.
68. Kovalchuk O., Tryndyak V.P., Montgomery B., Boyko A., Kutanzi K., Zemp F., Warbritton A.R., Latendresse J.R., Kovalchuk I., Beland F.A., Pogribny I.P. Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression. Cell Cycle 2007, 6:2010-2018.
69. Krebs C.J., Jarvis E.D., Chan J., Lydon J.P., Ogawa S., Pfaff D.W. A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors. Proc. Natl. Acad. Sci. USA 2000, 97:12816-12821.
70. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
71. Kuhn N.J. Progesterone withdrawal as the lactogenic trigger in the rat. J. Endocrinol. 1969, 44:39-54.
72. Kulshreshtha R., Ferracin M., Wojcik S.E., Garzon R., Alder H., Agosto-Perez F.J., Davuluri R., Liu C.G., Croce C.M., Negrini M., Calin G.A., Ivan M. A microRNA signature of hypoxia. Mol. Cell. Biol. 2007, 27:1859-1867.
73. Kuokkanen S., Chen B., Ojalvo L., Benard L., Santoro N., Pollard J.W. Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol. Reprod. 2010, 82:791-801.
74. Lai E.C. Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 2002, 30:363-364.
75. Lambert N.J., Gu S.G., Zahler A.M. The conformation of microRNA seed regions in native microRNPs is prearranged for presentation to mRNA targets. Nucleic Acids Res. 2011, 39:4827-4835.
76. Laraki G., Clerzius G., Daher A., Melendez-Pena C., Daniels S., Gatignol A. Interactions between the double-stranded RNA-binding proteins TRBP and PACT define the Medipal domain that mediates protein-protein interactions. RNA Biol. 2008, 5:92-103.
77. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Radmark O., Kim S., Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
78. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23:4051-4060.
79. Li L.C., Okino S.T., Zhao H., Pookot D., Place R.F., Urakami S., Enokida H., Dahiya R. Small dsRNAs induce transcriptional activation in human cells. Proc. Natl. Acad. Sci. USA 2006, 103:17337-17342.
80. Li R., Qiao J., Wang L., Li L., Zhen X., Liu P., Zheng X. MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration. Reprod Biol Endocrinol. 2011, 9:29.
81. Li R., Qiao J., Wang L., Zhen X., Lu Y. Serum progesterone concentration on day of HCG administration and IVF outcome. Reprod. Biomed. Online 2008, 16:627-631.
82. Liu J., Carmell M.A., Rivas F.V., Marsden C.G., Thomson J.M., Song J.J., Hammond S.M., Joshua-Tor L., Hannon G.J. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004, 305:1437-1441.
83. Loizzi R.F. Progesterone withdrawal stimulates mammary gland tubulin polymerization in pregnant rats. Endocrinology 1985, 116:2543-2547.
84. Lowery A.J., Miller N., Devaney A., McNeill R.E., Davoren P.A., Lemetre C., Benes V., Schmidt S., Blake J., Ball G., Kerin M.J. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res. 2009, 11:R27.
85. Lund E., Guttinger S., Calado A., Dahlberg J.E., Kutay U. Nuclear export of microRNA precursors. Science 2004, 303:95-98.
86. Luo X., Yin P., Coon V.J., Cheng Y.H., Wiehle R.D., Bulun S.E. The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells. Fertil. Steril. 2010, 93:2668-2673.
87. Maillot G., Lacroix-Triki M., Pierredon S., Gratadou L., Schmidt S., Benes V., Roche H., Dalenc F., Auboeuf D., Millevoi S., Vagner S. Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth. Cancer Res. 2009, 69:8332-8340.
88. Maisel M., Habisch H.J., Royer L., Herr A., Milosevic J., Hermann A., Liebau S., Brenner R., Schwarz J., Schroeder M., Storch A. Genome-wide expression profiling and functional network analysis upon neuroectodermal conversion of human mesenchymal stem cells suggest HIF-1 and miR-124a as important regulators. Exp. Cell Res. 2010, 316:2760-2778.
89. Mann M., Barad O., Agami R., Geiger B., Hornstein E. miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate. Proc. Natl. Acad. Sci. USA 2010, 107:15804-15809.
90. Martin B.L., Kimelman D. Developmental biology: micro(RNA)-managing nodal. Curr. Biol. 2007, 17:R975-R977.
91. Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 2004, 15:185-197.
92. Mesiano S., Chan E.C., Fitter J.T., Kwek K., Yeo G., Smith R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J. Clin. Endocrinol. Metab. 2002, 87:2924-2930.
93. Mishima T., Takizawa T., Luo S.S., Ishibashi O., Kawahigashi Y., Mizuguchi Y., Ishikawa T., Mori M., Kanda T., Goto T. MicroRNA (miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary. Reproduction 2008, 136:811-822.
94. Morita S., Horii T., Kimura M., Goto Y., Ochiya T., Hatada I. One Argonaute family member, Eif2c2 (Ago2), is essential for development and appears not to be involved in DNA methylation. Genomics 2007, 89:687-696.
95. Murashov A.K. A brief introduction to RNAi and microRNAs in stem cells. Methods Mol. Biol. 2010, 650:15-25.
96. Nguyen D.A., Parlow A.F., Neville M.C. Hormonal regulation of tight junction closure in the mouse mammary epithelium during the transition from pregnancy to lactation. J. Endocrinol. 2001, 170:347-356.
97. Nicoloso M.S., Sun H., Spizzo R., Kim H., Wickramasinghe P., Shimizu M., Wojcik S.E., Ferdin J., Kunej T., Xiao L., Manoukian S., Secreto G., Ravagnani F., Wang X., Radice P., Croce C.M., Davuluri R.V., Calin G.A. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 2010, 70:2789-2798.
98. Nothnick W.B., Healy C. Estrogen induces distinct patterns of microRNA expression within the mouse uterus. Reprod. Sci. 2010, 17:987-994.
99. Nothnick W.B., Healy C., Hong X. Steroidal regulation of uterine miRNAs is associated with modulation of the miRNA biogenesis components Exportin-5 and Dicer1. Endocrinology 2010, 37:265-273.
100. Ohlsson Teague E.M., Van der Hoek K.H., Van der Hoek M.B., Perry N., Wagaarachchi P., Robertson S.A., Print C.G., Hull L.M. MicroRNA-regulated pathways associated with endometriosis. Mol. Endocrinol. 2009, 23:265-275.
101. Okamura K., Liu N., Lai E.C. Distinct mechanisms for microRNA strand selection by Drosophila Argonautes. Mol. Cell 2009, 36:431-444.
102. Orom U.A., Nielsen F.C., Lund A.H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 2008, 30:460-471.
103. Pampalakis G., Diamandis E.P., Katsaros D., Sotiropoulou G. Down-regulation of dicer expression in ovarian cancer tissues. Clin. Biochem. 2009, 43:324-327.
104. Pan Q., Luo X., Chegini N. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J. Cell Mol. Med. 2008, 12:227-240.
105. Pan Q., Luo X., Toloubeydokhti T., Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol. Hum. Reprod. 2007, 13:797-806.
106. Pandey D.P., Picard D. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol. Cell. Biol. 2009, 29:3783-3790.
107. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22:894-907.
108. Peluso J.J., Liu X., Saunders M.M., Claffey K.P., Phoenix K. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1. J. Clin. Endocrinol. Metab. 2008, 93:1592-1599.
109. Pillai R.S., Bhattacharyya S.N., Artus C.G., Zoller T., Cougot N., Basyuk E., Bertrand E., Filipowicz W. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 2005, 309:1573-1576.
110. Place R.F., Li L.C., Pookot D., Noonan E.J., Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. USA 2008, 105:1608-1613.
111. Rehwinkel J., Behm-Ansmant I., Gatfield D., Izaurralde E. A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 2005, 11:1640-1647.
112. Renthal N.E., Chen C.C., Williams K.C., Gerard R.D., Prange-Kiel J., Mendelson C.R. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc. Natl. Acad. Sci. USA 2010, 107:20828-20833.
113. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 2002, 277:5209-5218.
114. Rigoutsos I. New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res. 2009, 69:3245-3248.
115. Ro S., Song R., Park C., Zheng H., Sanders K.M., Yan W. Cloning and expression profiling of small RNAs expressed in the mouse ovary. RNA 2007, 13:2366-2380.
116. Ruby J.G., Jan C.H., Bartel D.P. Intronic microRNA precursors that bypass Drosha processing. Nature 2007, 448:83-86.
117. Samavarchi-Tehrani P., Golipour A., David L., Sung H.K., Beyer T.A., Datti A., Woltjen K., Nagy A., Wrana J.L. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010, 7:64-77.
118. Schwartz J.C., Younger S.T., Nguyen N.B., Hardy D.B., Monia B.P., Corey D.R., Janowski B.A. Antisense transcripts are targets for activating small RNAs. Nat. Struct. Mol. Biol. 2008, 15:842-848.
119. Sdassi N., Silveri L., Laubier J., Tilly G., Costa J., Layani S., Vilotte J.L., Le Provost F. Identification and characterization of new miRNAs cloned from normal mouse mammary gland. BMC Genom. 2009, 10:149.
120. Seggerson K., Tang L., Moss E.G. Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev. Biol. 2002, 243:215-225.
121. Sempere L.F., Christensen M., Silahtaroglu A., Bak M., Heath C.V., Schwartz G., Wells W., Kauppinen S., Cole C.N. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 2007, 67:11612-11620.
122. Shimono Y., Zabala M., Cho R.W., Lobo N., Dalerba P., Qian D., Diehn M., Liu H., Panula S.P., Chiao E., Dirbas F.M., Somlo G., Pera R.A., Lao K., Clarke M.F. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009, 138:592-603.
123. Shomron N., Golan D., Hornstein E. An evolutionary perspective of animal microRNAs and their targets. J. Biomed. Biotechnol. 2009, 2009:594738.
124. Shulman A., Ghetler Y., Beyth Y., Ben-Nun I. The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a " long protocol" of gonadotropin releasing hormone analogue and human menopausal gonadotropins. J. Assist. Reprod. Genet. 1996, 13:207-211.
125. Silveri L., Tilly G., Vilotte J.L., Le Provost F. MicroRNA involvement in mammary gland development and breast cancer. Reprod. Nutr. Dev. 2006, 46:549-556.
126. Sirotkin A.V., Ovcharenko D., Grossmann R., Laukova M., Mlyncek M. Identification of microRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen. J. Cell. Physiol. 2009, 219:415-420.
127. Spoelstra N.S., Manning N.G., Higashi Y., Darling D., Singh M., Shroyer K.R., Broaddus R.R., Horwitz K.B., Richer J.K. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res. 2006, 66:3893-3902.
128. Szarzynska B., Sobkowiak L., Pant B.D., Balazadeh S., Scheible W.R., Mueller-Roeber B., Jarmolowski A., Szweykowska-Kulinska Z. Gene structures and processing of Arabidopsis thaliana HYL1-dependent pri-miRNAs. Nucleic Acids Res. 2009, 37:3083-3093.
129. Toloubeydokhti T., Pan Q., Luo X., Bukulmez O., Chegini N. The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod. Sci. 2008, 15:993-1001.
130. Valastyan S., Weinberg R.A. MicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis. Cell Cycle 2009, 8:3506-3512.
131. Vella M.C., Choi E.Y., Lin S.Y., Reinert K., Slack F.J. The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3'UTR. Genes Dev. 2004, 18:132-137.
132. Viville B., Charnock-Jones D.S., Sharkey A.M., Wetzka B., Smith S.K. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium. Hum. Reprod. 1997, 12:815-822.
133. Wang C., Li Q. Identification of differentially expressed microRNAs during the development of Chinese murine mammary gland. J. Genet. Genom. 2007, 34:966-973.
134. Wendler A., Keller D., Albrecht C., Peluso J.J., Wehling M. Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells. Oncol. Rep. 2011, 25:273-279.
135. Williams A.H., Liu N., van Rooij E., Olson E.N. MicroRNA control of muscle development and disease. Curr. Opin. Cell Biol. 2009, 21:461-469.
136. Wittmann J., Jack H.M. Serum microRNAs as powerful cancer biomarkers. Biochim. Biophys. Acta 2010, 1806:200-207.
137. Wu L., Fan J., Belasco J.G. MicroRNAs direct rapid deadenylation of mRNA. Proc. Natl. Acad. Sci. USA 2006, 103:4034-4039.
138. Wu Y., Strawn E., Basir Z., Halverson G., Guo S.W. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 2006, 1:106-111.
139. Xia H.F., Jin X.H., Song P.P., Cui Y., Liu C.M., Ma X. Temporal and spatial regulation of let-7a in the uterus during embryo implantation in the rat. J. Reprod. Dev. 2010, 56:73-78.
140. Xia H.F., Jin X.H., Song P.P., Cui Y., Liu C.M., Ma X. Temporal and spatial regulation of miR-320 in the uterus during embryo implantation in the rat. Int. J. Mol. Sci. 2010, 11:719-730.
141. Yamashita A., Chang T.C., Yamashita Y., Zhu W., Zhong Z., Chen C.Y., Shyu A.B. Concerted action of poly(A) nucleases and decapping enzyme in mammalian mRNA turnover. Nat. Struct. Mol. Biol. 2005, 12:1054-1063.
142. Yao N., Lu C.L., Zhao J.J., Xia H.F., Sun D.G., Shi X.Q., Wang C., Li D., Cui Y., Ma X. A network of miRNAs expressed in the ovary are regulated by FSH. Front Biosci. 2009, 14:3239-3245.
143. Yi R., Doehle B.P., Qin Y., Macara I.G., Cullen B.R. Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. RNA 2005, 11:220-226.
144. Yi R., Fuchs E. MicroRNA-mediated control in the skin. Cell Death Differ. 2010, 17:229-235.
145. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17:3011-3016.
146. Yoshida S., Ohara N., Xu Q., Chen W., Wang J., Nakabayashi K., Sasaki H., Morikawa A., Maruo T. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. Semin. Reprod. Med. 2010, 28:260-273.
147. Younger S.T., Corey D.R. The puzzle of RNAs that target gene promoters. ChemBioChem 2009, 10:1135-1139.
148. Younger S.T., Corey D.R. Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Res. 2011, 39:5682-5691.
149. Yue X., Schwartz J.C., Chu Y., Younger S.T., Gagnon K.T., Elbashir S., Janowski B.A., Corey D.R. Transcriptional regulation by small RNAs at sequences downstream from 3' gene termini. Nat. Chem. Biol. 2010, 6:621-629.
150. Zavadil J., Ye H., Liu Z., Wu J., Lee P., Hernando E., Soteropoulos P., Toruner G.A., Wei J.J. Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas. PLoS ONE 2010, 5:e12362.
151. Zhao J.J., Lin J., Yang H., Kong W., He L., Ma X., Coppola D., Cheng J.Q. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J. Biol. Chem. 2008, 283:31079-31086.
152. Zheng H., Song F., Zhang L., Yang D., Ji P., Wang Y., Almeida M., Calin G.A., Hao X., Wei Q., Zhang W., Chen K. Genetic variants at the miR-124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer. Int. J. Oncol. 2011, 38:1153-1161.
153. Zhu W., Qin W., Atasoy U., Sauter E.R. Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes 2009, 2:89.